BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 3:57:00 PM | Browse: 1546 | Download: 1540
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Melatonin and derivatives as promising tools for glaucoma treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hanan Awad Alkozi and Jesús Pintor |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Universidad Complutense de Madrid |
GR35/10-A-920777 |
| Ministry of Economy |
SAF 2010/16024 |
| Institute Carlos III |
RETICS RD12/0034/0003 |
|
| Corresponding Author |
Jesús Pintor, Professor, Department of Biochemistry and Molecular Biology IV, Faculty of Optics and Optometry, Universidad Complutense de Madrid, c/Arcos de Jalón 118, E-28037 Madrid, Spain. jpintor@ucm.es |
| Key Words |
5-MCA-NAT; IIK7; Glaucoma; Ocular hypertension; Melatonin |
| Core Tip |
This mini review depicts the main features of melatonin and derivatives as interesting agents for the treatment of the ocular hypertension associated with glaucoma. |
| Publish Date |
2013-12-19 18:57 |
| Citation |
Alkozi HA, Pintor J. Melatonin and derivatives as promising tools for glaucoma treatment. World J Ophthalmol 2013; 3(4): 32-37
|
| URL |
http://www.wjgnet.com/2218-6239/full/v3/i4/32.htm |
| DOI |
http://dx.doi.org/10.5318/wjo.v3.i4.32 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.